Pfizer (PFE) Divestments (2012 - 2026)

Pfizer (PFE) has reported Divestments for 6 consecutive years, with $1.9 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Divestments changed N/A year-over-year to $1.9 billion in Q2 2026; TTM through Jun 2026 was $1.9 billion, a 80.87% decrease from a year earlier, with the FY2025 full-year figure at $6.3 billion, down 10.36% from the prior year.
• Divestments was $1.9 billion for Q2 2026 at Pfizer, down from $6.3 billion in the prior quarter.
• Over five years, Divestments peaked at $6.3 billion in Q1 2025 and troughed at $1.9 billion in Q2 2026.
• A 3-year average of $3.8 billion and a median of $3.5 billion in 2024 frame the typical range for Divestments.
• The widest YoY moves for Divestments: up 80.78% in 2025, down 80.78% in 2025.
• Over 3 years, Divestments stood at $3.5 billion in 2024, then soared by 80.78% to $6.3 billion in 2025, then tumbled by 70.29% to $1.9 billion in 2026.
• The last three Divestments figures came in at $1.9 billion (Q2 2026), $6.3 billion (Q1 2025), and $3.5 billion (Q3 2024), per Business Quant data.